Chargement en cours...
Pioglitazone Alters the Proteomes of Normal Bladder Epithelial Cells but Shows No Tumorigenic Effects
PURPOSE: Pioglitazone, an antihyperglycemic drug, is widely used in diabetes mellitus patients with insulin resistance. Although pioglitazone is known to have a potential link to bladder cancer (BC), there have been contradictory results. This present study is designed to understand the regulatory m...
Enregistré dans:
| Publié dans: | Int Neurourol J |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Korean Continence Society
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7136443/ https://ncbi.nlm.nih.gov/pubmed/32252184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5213/inj.1938186.093 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|